| Identification | Back Directory | [Name]
2-AMino-6-chloropurine-9-(2'-O-Methyl)riboside | [CAS]
194034-59-8 | [Synonyms]
2-AMino-6-chloropurine-9-(2'-O-Methyl)riboside
9H-Purin-2-amine, 6-chloro-9-(2-O-methyl-β-D-ribofuranosyl)-
6-chloro-9-(2-O-Methyl-beta-D-ribofuranosyl)-9H-purin-2-aMine
2-AMino-6-chloro-9-(2'-O
-Methyl-beta-D-ribofuranosyl)-9H-purine
(2R,3R,4R,5R)-5-(2-Amino-6-chloro-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol | [Molecular Formula]
C11H14ClN5O4 | [MOL File]
194034-59-8.mol | [Molecular Weight]
315.71 |
| Hazard Information | Back Directory | [Uses]
6-Chloro-9-(2-O-methyl-beta-D-ribofuranosyl)-9H-purin-2-amine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|